chr1-215970707-C-T

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2

The NM_206933.4(USH2A):​c.6875G>A​(p.Arg2292His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0269 in 1,613,568 control chromosomes in the GnomAD database, including 781 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R2292C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.020 ( 48 hom., cov: 32)
Exomes 𝑓: 0.028 ( 733 hom. )

Consequence

USH2A
NM_206933.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9O:1

Conservation

PhyloP100: 0.0800
Variant links:
Genes affected
USH2A (HGNC:12601): (usherin) This gene encodes a protein that contains laminin EGF motifs, a pentaxin domain, and many fibronectin type III motifs. The protein is found in the basement membrane, and may be important in development and homeostasis of the inner ear and retina. Mutations within this gene have been associated with Usher syndrome type IIa and retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

PM1
In a domain Fibronectin type-III 9 (size 87) in uniprot entity USH2A_HUMAN there are 41 pathogenic changes around while only 8 benign (84%) in NM_206933.4
BP4
Computational evidence support a benign effect (MetaRNN=0.002261877).
BP6
Variant 1-215970707-C-T is Benign according to our data. Variant chr1-215970707-C-T is described in ClinVar as [Benign]. Clinvar id is 48571.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-215970707-C-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0195 (2972/152152) while in subpopulation NFE AF= 0.0288 (1956/67996). AF 95% confidence interval is 0.0277. There are 48 homozygotes in gnomad4. There are 1454 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 48 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
USH2ANM_206933.4 linkc.6875G>A p.Arg2292His missense_variant Exon 36 of 72 ENST00000307340.8 NP_996816.3 O75445-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
USH2AENST00000307340.8 linkc.6875G>A p.Arg2292His missense_variant Exon 36 of 72 1 NM_206933.4 ENSP00000305941.3 O75445-1
USH2AENST00000674083.1 linkc.6875G>A p.Arg2292His missense_variant Exon 36 of 73 ENSP00000501296.1 O75445-3

Frequencies

GnomAD3 genomes
AF:
0.0195
AC:
2972
AN:
152034
Hom.:
48
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00507
Gnomad AMI
AF:
0.0910
Gnomad AMR
AF:
0.00820
Gnomad ASJ
AF:
0.0109
Gnomad EAS
AF:
0.000580
Gnomad SAS
AF:
0.0139
Gnomad FIN
AF:
0.0433
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0288
Gnomad OTH
AF:
0.0139
GnomAD3 exomes
AF:
0.0214
AC:
5374
AN:
251062
Hom.:
99
AF XY:
0.0222
AC XY:
3008
AN XY:
135676
show subpopulations
Gnomad AFR exome
AF:
0.00455
Gnomad AMR exome
AF:
0.00606
Gnomad ASJ exome
AF:
0.0101
Gnomad EAS exome
AF:
0.000109
Gnomad SAS exome
AF:
0.0149
Gnomad FIN exome
AF:
0.0442
Gnomad NFE exome
AF:
0.0303
Gnomad OTH exome
AF:
0.0212
GnomAD4 exome
AF:
0.0276
AC:
40391
AN:
1461416
Hom.:
733
Cov.:
32
AF XY:
0.0271
AC XY:
19675
AN XY:
727002
show subpopulations
Gnomad4 AFR exome
AF:
0.00383
Gnomad4 AMR exome
AF:
0.00654
Gnomad4 ASJ exome
AF:
0.00976
Gnomad4 EAS exome
AF:
0.000302
Gnomad4 SAS exome
AF:
0.0159
Gnomad4 FIN exome
AF:
0.0441
Gnomad4 NFE exome
AF:
0.0311
Gnomad4 OTH exome
AF:
0.0235
GnomAD4 genome
AF:
0.0195
AC:
2972
AN:
152152
Hom.:
48
Cov.:
32
AF XY:
0.0195
AC XY:
1454
AN XY:
74374
show subpopulations
Gnomad4 AFR
AF:
0.00506
Gnomad4 AMR
AF:
0.00818
Gnomad4 ASJ
AF:
0.0109
Gnomad4 EAS
AF:
0.000581
Gnomad4 SAS
AF:
0.0141
Gnomad4 FIN
AF:
0.0433
Gnomad4 NFE
AF:
0.0288
Gnomad4 OTH
AF:
0.0137
Alfa
AF:
0.0263
Hom.:
58
Bravo
AF:
0.0167
TwinsUK
AF:
0.0280
AC:
104
ALSPAC
AF:
0.0353
AC:
136
ESP6500AA
AF:
0.00545
AC:
24
ESP6500EA
AF:
0.0303
AC:
261
ExAC
AF:
0.0224
AC:
2719
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.0256
EpiControl
AF:
0.0240

ClinVar

Significance: Benign
Submissions summary: Benign:9Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3Other:1
Sep 20, 2018
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
NEI Ophthalmic Genomics Laboratory, National Institutes of Health
Significance: not provided
Review Status: no classification provided
Collection Method: literature only

- -

not specified Benign:2
Jun 24, 2009
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Oct 17, 2013
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Usher syndrome type 2A Benign:2
Sep 16, 2020
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Nov 04, 2023
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Retinitis pigmentosa 39 Benign:1
Nov 04, 2023
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Retinal dystrophy Benign:1
Oct 01, 2023
Dept Of Ophthalmology, Nagoya University
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.056
BayesDel_addAF
Benign
-0.68
T
BayesDel_noAF
Benign
-0.72
CADD
Benign
0.90
DANN
Benign
0.86
DEOGEN2
Benign
0.022
T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.020
N
LIST_S2
Benign
0.68
T
MetaRNN
Benign
0.0023
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.55
N
PrimateAI
Benign
0.20
T
PROVEAN
Benign
1.0
N
REVEL
Benign
0.056
Sift
Benign
0.61
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.044
MPC
0.034
ClinPred
0.0022
T
GERP RS
0.79
Varity_R
0.027
gMVP
0.26

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs41277210; hg19: chr1-216144049; COSMIC: COSV56448114; API